List of Tables
Table 1. Global HPV Testing Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global HPV Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global HPV Testing Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global HPV Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global HPV Testing Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global HPV Testing Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global HPV Testing Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global HPV Testing Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global HPV Testing Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. HPV Testing Revenue by Company (2020-2025) & (US$ Million)
Table 11. HPV Testing Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top HPV Testing Players by Revenue (US$ Million) in 2024
Table 13. Global HPV Testing Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global HPV Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Testing as of 2024)
Table 15. Global HPV Testing Companies Headquarters
Table 16. Date of International Companies Enter into HPV Testing Market
Table 17. Global HPV Testing Companies Product & Service
Table 18. Global HPV Testing Mergers & Acquisitions, Expansion Plans
Table 19. Qiagen Corporation Information
Table 20. Qiagen Description and Business Overview
Table 21. Qiagen HPV Testing Product
Table 22. Qiagen HPV Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Qiagen Revenue Proportion of HPV Testing by Product in 2024
Table 24. Qiagen Revenue Proportion of HPV Testing by Application in 2024
Table 25. Qiagen Revenue Proportion of HPV Testing by Geographic Area in 2024
Table 26. Qiagen Recent Developments
Table 27. Roche Diagnostics Corporation Information
Table 28. Roche Diagnostics Description and Business Overview
Table 29. Roche Diagnostics HPV Testing Product
Table 30. Roche Diagnostics HPV Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Roche Diagnostics Revenue Proportion of HPV Testing by Product in 2024
Table 32. Roche Diagnostics Revenue Proportion of HPV Testing by Application in 2024
Table 33. Roche Diagnostics Revenue Proportion of HPV Testing by Geographic Area in 2024
Table 34. Roche Diagnostics Recent Developments
Table 35. Hologic Corporation Information
Table 36. Hologic Description and Business Overview
Table 37. Hologic HPV Testing Product
Table 38. Hologic HPV Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Hologic Revenue Proportion of HPV Testing by Product in 2024
Table 40. Hologic Revenue Proportion of HPV Testing by Application in 2024
Table 41. Hologic Revenue Proportion of HPV Testing by Geographic Area in 2024
Table 42. Hologic Recent Developments
Table 43. Abbott Laboratories Corporation Information
Table 44. Abbott Laboratories Description and Business Overview
Table 45. Abbott Laboratories HPV Testing Product
Table 46. Abbott Laboratories HPV Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Abbott Laboratories Revenue Proportion of HPV Testing by Product in 2024
Table 48. Abbott Laboratories Revenue Proportion of HPV Testing by Application in 2024
Table 49. Abbott Laboratories Revenue Proportion of HPV Testing by Geographic Area in 2024
Table 50. Abbott Laboratories Recent Developments
Table 51. BD Corporation Information
Table 52. BD Description and Business Overview
Table 53. BD HPV Testing Product
Table 54. BD HPV Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. BD Revenue Proportion of HPV Testing by Product in 2024
Table 56. BD Revenue Proportion of HPV Testing by Application in 2024
Table 57. BD Revenue Proportion of HPV Testing by Geographic Area in 2024
Table 58. BD Recent Developments
Table 59. Seegene, Inc. Corporation Information
Table 60. Seegene, Inc. Description and Business Overview
Table 61. Seegene, Inc. HPV Testing Product
Table 62. Seegene, Inc. HPV Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Seegene, Inc. Revenue Proportion of HPV Testing by Product in 2024
Table 64. Seegene, Inc. Revenue Proportion of HPV Testing by Application in 2024
Table 65. Seegene, Inc. Revenue Proportion of HPV Testing by Geographic Area in 2024
Table 66. Seegene, Inc. Recent Developments
Table 67. North America HPV Testing Revenue by Country (2020-2025) & (US$ Million)
Table 68. North America HPV Testing Revenue by Country (2026-2031) & (US$ Million)
Table 69. North America HPV Testing Revenue by Type (2020-2025) & (US$ Million)
Table 70. North America HPV Testing Revenue by Application (2020-2025) & (US$ Million)
Table 71. Asia-Pacific HPV Testing Revenue by Region (2020-2025) & (US$ Million)
Table 72. Asia-Pacific HPV Testing Revenue by Region (2026-2031) & (US$ Million)
Table 73. Asia-Pacific HPV Testing Revenue by Type (2020-2025) & (US$ Million)
Table 74. Asia-Pacific HPV Testing Revenue by Application (2020-2025) & (US$ Million)
Table 75. Europe HPV Testing Revenue by Country (2020-2025) & (US$ Million)
Table 76. Europe HPV Testing Revenue by Country (2026-2031) & (US$ Million)
Table 77. Europe HPV Testing Revenue by Type (2020-2025) & (US$ Million)
Table 78. Europe HPV Testing Revenue by Application (2020-2025) & (US$ Million)
Table 79. Latin America HPV Testing Revenue by Country (2020-2025) & (US$ Million)
Table 80. Latin America HPV Testing Revenue by Country (2026-2031) & (US$ Million)
Table 81. Latin America HPV Testing Revenue by Type (2020-2025) & (US$ Million)
Table 82. Latin America HPV Testing Revenue by Application (2020-2025) & (US$ Million)
Table 83. Middle East and Africa HPV Testing Revenue by Country (2020-2025) & (US$ Million)
Table 84. Middle East and Africa HPV Testing Revenue by Country (2026-2031) & (US$ Million)
Table 85. Middle East and Africa HPV Testing Revenue by Type (2020-2025) & (US$ Million)
Table 86. Middle East and Africa HPV Testing Revenue by Application (2020-2025) & (US$ Million)
Table 87. HPV Testing Key Raw Materials, Industry Status and Trend
Table 88. HPV Testing Key Raw Materials and Upstream Suppliers
Table 89. HPV Testing Clients Status and Trend
Table 90. HPV Testing Typical Clients
Table 91. HPV Testing Distributors
Table 92. HPV Testing Market Trends
Table 93. HPV Testing Market Drivers
Table 94. HPV Testing Market Challenges
Table 95. HPV Testing Market Restraints
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. HPV Testing Product Picture
Figure 2. Global HPV Testing Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global HPV Testing Revenue Market Share by Type in 2024 & 2031
Figure 4. HPV Testing Product Picture
Figure 5. Follow-up HPV Testing Product Picture
Figure 6. Co-testing Product Picture
Figure 7. Global HPV Testing Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global HPV Testing Revenue Market Share by Application in 2024 & 2031
Figure 9. Cervical Cancer Screening
Figure 10. Vaginal Cancer Screening
Figure 11. Other
Figure 12. HPV Testing Report Years Considered
Figure 13. Global HPV Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global HPV Testing Market Size (2020-2031) & (US$ Million)
Figure 15. Global HPV Testing Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global HPV Testing Revenue Market Share by Region (2020-2031)
Figure 17. Global HPV Testing Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global HPV Testing Revenue Market Share Forecast by Application (2020-2031)
Figure 19. HPV Testing of HPV Testing Revenue Market Share by Application, 2024 VS 2031
Figure 20. Follow-up HPV Testing of HPV Testing Revenue Market Share by Application, 2024 VS 2031
Figure 21. Co-testing of HPV Testing Revenue Market Share by Application, 2024 VS 2031
Figure 22. HPV Testing Revenue Share by Company (2024)
Figure 23. HPV Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. HPV Testing Revenue Proportion by Company in 2024
Figure 25. Follow-up HPV Testing Revenue Proportion by Company in 2024
Figure 26. Co-testing Revenue Proportion by Company in 2024
Figure 27. North America HPV Testing Revenue 2020-2031 (US$ Million)
Figure 28. North America HPV Testing Revenue Market Share by Type (2020-2025)
Figure 29. North America HPV Testing Revenue Market Share by Application (2020-2025)
Figure 30. Asia-Pacific HPV Testing Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific HPV Testing Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific HPV Testing Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific HPV Testing Revenue Market Share by Application (2020-2025)
Figure 34. Europe HPV Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe HPV Testing Revenue Market Share by Country (2020-2031)
Figure 36. Europe HPV Testing Revenue Market Share by Type (2020-2025)
Figure 37. Europe HPV Testing Revenue Market Share by Application (2020-2025)
Figure 38. Latin America HPV Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America HPV Testing Revenue Market Share by Country (2020-2031)
Figure 40. Latin America HPV Testing Revenue Market Share by Type (2020-2025)
Figure 41. Latin America HPV Testing Revenue Market Share by Application (2020-2025)
Figure 42. Middle East and Africa HPV Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa HPV Testing Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa HPV Testing Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa HPV Testing Revenue Market Share by Application (2020-2025)
Figure 46. HPV Testing Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of HPV Testing Raw Materials by Region in 2024
Figure 48. HPV Testing Distribution Channels
Figure 49. Global HPV Testing Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global HPV Testing Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed